Nalaganje...

Use of Cannabinoids as a Novel Therapeutic Modality Against Autoimmune Hepatitis

Autoimmune hepatitis is a severe immune mediated chronic liver disease with a prevalence range between 50 and 200 cases per million in Western Europe and North America and mortality rates of up to 80% in untreated patients. The induction of CB1 and CB2 cannabinoid receptors during liver injury and t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Pandey, Rupal, Hegde, Venkatesh L., Singh, Narendra P., Hofseth, Lorne, Singh, Uday, Ray, Swapan, Nagarkatti, Mitzi, Nagarkatti, Prakash S.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139007/
https://ncbi.nlm.nih.gov/pubmed/19647124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0083-6729(09)81019-4
Oznake: Označite
Brez oznak, prvi označite!